th advances in cancer research & therapy...advances in cancer research & therapy november...

Advances in Cancer Research & Therapy November 11-12, 2019Madrid, Spain

38th Annual conference on

S C I E N T I F I C P R O G R A M

conferenceseries.com

SCIENTIFIC PROGRAM

Monday, 11th November DAY 1Monday, 11th November

08:30-09:00 Registrations

09:00-09:30 Introduction

09:30-09:50 COFFEE BREAK

09:50-11:50 Meeting Hall 01

KEYNOTE LECTURES

MEETING HALL 01 MEETING HALL 02

11:50-13:10 Talks On: Cancer Therapy | Cancer Research Talks On: Chemotherapy | Radiation Therapy

Hormonal Therapy Adjuvant chemotherapy

Cancer stem cell and immunology model Electrochemotherapy

Cancer Biopsy Combination chemotherapy

Tumor cells grown Cytoxic chemotherapy

13:10-13:15 GROUP PHOTO

13:15-14:00 LUNCH BREAK


14:00-16:00 Talks On: Organ Specific Cancers | Cancer Science

Talks On: Cancer Imaging | Cancer Nanotechnology

Colonoscopy pH-activated nanoparticles

Breast Cancer Iodine nanoparticle radiotherapy

Leukaemia Clinical Imaging

Clinical Research Alpha-fetoprotein blood test

Cell, Molecular, and Stem Cell Biology Nanoparticles in cancer therapy and diagnosis

Design and discovery of new drugs Pap test and human papillomavirus (HPV) testing


MEETING HALL 01 (16:20-17:00) MEETING HALL 01 (17:00-18:00)

Young Researchers in Oncology Workshop

Visit: https://cancertherapy.europeannualconferences.com/

SCIENTIFIC PROGRAM

Tuesday, 12th November DAY 2Tuesday, 12th November

09:00-10:30 Meeting Hall 01

KEYNOTE LECTURES



10:50-12:50 Talks On: Cancer Biology & Cancer Metastasis | Targeted therapies

Talks On: Cancer Stem Cell Therapy | Cancer Therapeutics

Cancer Immunology Cancer Stem cells

Cellular Immunotherapy Cancer Stem cell Therapy Procedure

Epigenetics Molecular cancer therapeutics

Antihormone therapy Mitochondrial redox homeostasis

Biotechnology Research Large molecule therapeutic

Reoviridae Gene-Environment Interactions

12:50-13:35 LUNCH BREAK


13:35-15:55 Talks On: Cancer Genetics | Cancer Bioinformatics

Talks On: Cancer Pharmacology | Surgical Oncology

Cancer gene discovery Clinical Trial Information

Proteomics Molecular Targeted Therapy

Genes involved in cancer Design and discovery of new drugs

Cancer Drug Discovery Biotechnology Research

Precision Oncology Hormonal Drug Therapy

Structural Bioinformatics Colonoscopy

Epigenetic Gynaecological Surgery


MEETING HALL 01 (16:15-17:00) MEETING HALL 01 (17:00-18:00)

Poster Presentations Workshop


Alvaro Macieira-Coelho French National Institute of Health (INSERM), France

Liane Deligdisch Icahn School of Medicine at Mount Sinai, USA

Tatiana Massarrah Gregorio Maranon Hospital, Spain

Sherry A Bradford AccuTheranostics, Inc., USA

Aleksandar Stefanovic Clinical Center of Serbia, Serbia

Nyla A Heerema The Ohio State University Wexner Medical Center, USA

Charles L Hitchcock The Ohio State University, USA

Alice Dragomir McGill University, Canada

M Helena Vasconcelos University of Porto, Portugal

Rita Lakhani Krishna University of Health Sciences, India

Audrey Claing Montreal University, Canada

Hirendra Nath Banerjee University of North Carolina, USA

Katarina Jeremic University of Belgrade, Serbia

Vasco Fonseca Centro Hospitalar Lisboa Ocidental, Portugal

Isaura Meza CINVESTAV, Mexico

Robert Thomas Bedford and Addenbrooke’s Cambridge University Hospitals, UK

Shanmugasundaram Ganapathy Kanniappan Johns Hopkins University, USA

Qi-Fei Wang The First Affiliated Hospital of Dalian Medical University, China

Kuniaki Arai Kanazawa University Hospital, Japan

Adnan Yousif Rojeab London College UCK, UK

Wioletta Rozpędek Medical University of Lodz, Poland

M Inês Silva University of Porto, Portuga

Diana Sousa University of Porto, Portugal

PAST AFFILIATESPA

ST A

FFIL

IATE

S


Joana Pereira University of Porto, Portugal

Liyun Shi Hangzhou Normal University School of Medicine, China

Gina Marcela Méndez-Callejas University of Applied and Environmental Sciences, Colombia

Maria Isabel da G. S. Ramos University of Cape Verde, Africa



Sonia A Melo University of Porto, Portugal

Zofia Felicja Bielecka Warsaw Medical University, Poland

Mahmood Faraz Umea University, Sweden

Carolina F Ruivo Institute for Research and Innovation in Health, Portugal

Nuno Bastos University of Porto, Portugal

So Young Kim Chungbuk National University, South Korea

Sung S Choi Chung-Ang University College of Medicine, South Korea

Leclerc Anne-France University Hospital Centre of Liege, Belgium


Madiha Nazir Uppsala University, Sweden

Fouad Azizi Hamad Medical Corporation, Qatar

Andrés Julián Gutiérrez-Escobar University of Applied and Environmental Sciences, Colombia

Purusottam Mohapatra Lund University, Sweden

Messafeur Abdelkrim University Sidi Bel Abbes, Algeria

Maria Isabel da G. S. Ramos

University of Cape Verde, Africa



PAST AFFILIATESPA

ST A

FFIL

IATE

S


Sonia A Melo University of Porto, Portugal

Zofia Felicja Bielecka Warsaw Medical University, Poland


Carolina F Ruivo Institute for Research and Innovation in Health, Portugal

Nuno Bastos University of Porto, Portugal

So Young Kim Chungbuk National University, South Korea

Sung S Choi Chung-Ang University College of Medicine, South Korea

Leclerc Anne-France University Hospital Centre of Liege, Belgium


Madiha Nazir

Uppsala University, Sweden

Fouad Azizi Hamad Medical Corporation, Qatar

Andrés Julián Gutiérrez-Escobar University of Applied and Environmental Sciences, Colombia

Purusottam Mohapatra Lund University, Sweden

Messafeur Abdelkrim University Sidi Bel Abbes, Algeria

Sanjay Gandhi Southmead Hospital, UK

Vikas Leelavati Balasaheb Jadhav Dr.D.Y.Patil University, India

Abdulrahman A. S. Alsayyari Qassim University, Saudi Arabia

Masoud Hashemi Shahid Beheshti University of Medical Sciences, Iran

Hissa Mohammed National center for Cancer Care and Research, Qatar

Chih-Jen Hung Taichung Veterans General Hospital, Taiwan

M. A. Alnafea King Saud University, Saudi Arabia

Monica Kansal Jaypee Hospital, India

David Sipos University of Pecs Faculty of Health Sciences, Hungary

PAST AFFILIATESPA

ST A

FFIL

IATE

S


PAST AFFILIATESPA

ST A

FFIL

IATE

S


Amjed Eljaili Ysbyty Gwynedd, UK

Shahriari Mozhgan Tehran University, Iran

Daniel L. Farkas University of Southern California, USA

Claudia Paola Rivera-Uribe Nuevo León Autonomous University, Mexico

Ala khasawneh University of Pécs, Hungary

Syed Muhammad Anwar University of Engineering and Technology, Pakistan

Kunwarpal singh Sri Guru Ram Das Institute of Medical Sciences and Research, India

Shajeem Shahudeen Vivid Diagnostic Centre, India

Dongyeon Lee Yonsei University, South Korea

M. A. Alnafea King Saud University, Saudi Arabia

David Sipos University of Pecs Faculty of Health Sciences, Hungary

Ala khasawneh University of Pécs, Hungary

Mustafa Sabil United Kingdom

Zang-Hee Cho Seoul National University, South Korea

Bin Zheng University of Oklahoma, USA

Michael L Goris Stanford University School of Medicine, USA

Bital Savir-Baruch Loyola University Medical Center, USA

Ilona Kowalik-Urbaniak Client Outlook Inc., Canada

Monika Beresova University of Debrecen, Hungary

Hang Joon Jo Mayo Clinic, USA

Elaine Iuanow Cleveland Clinic Foundation, USA

Barath Narayanan Narayanan University of Dayton, USA

Jamal Zweit Virginia Commonwealth University, USA

David A Gutman Emory University School of Medicine, USA

PAST AFFILIATESPA

ST A

FFIL

IATE

S


Limin Yang University of Iowa, USA

Tamara Feygin University of Pennsylvania, USA

Hesham El Sheikh Benha University, Egypt

Manohar Roda University of Mississippi, USA

Daniel Pastore Sao Paulo University School of Medicine, Brazil

Mafalda Gomes University of Porto, Portugal

Nilda Espinola-Zavaleta National Institute of Cardiology Ignacio Chavez, Mexico

Svjetlana Jefic University Clinical Centre of Repablic of Srpska, Bosnia and Herzegovina

Aminur Rahman National Institute of Neurosciences and Hospital, Bangladesh

Shivaram Poigai Arunachalam Mayo Clinic, USA


Sci

en

tific

Pro

gra

m

36th World Cancer ConferenceOctober 11-13, 2018 | Zurich, Switzerland

UK: Conference Series LLC Ltd47 Churchfield Road, London, W3 6AY

Toll Free: +1-800-014-8923



DAY-1 October 11, 2018

Meeting Hall: Paris

08:00-08:30 Registrations

Opening Ceremony 08:30-08:50Keynote Forum


09:00-09:30Title: Selective properties of the anticancer proton preparation on basis of Greater celandine alkaloids NSC 631570 (Ukrain) Wassil Nowicky, Ukrainian Anti-Cancer Institute, Austria

09:30-10:00Title: How telomerase biology affects cancer biology, chemotherapy and aging Joan Smith Sonneborn, University of Wyoming, USA

10:00-10:30Title: Autonomous self navigating nanovehicles—Novel paradigm in targeted cancer chemotherapy Valery A. Petrenko, Auburn University, USA

10:30-11:00Title: Why campaign against colorectal cancer? Luc Colemont, CEO Stop Darmkanker Foundation, Belgium

Networking & Refreshments 11:00-11:20 @ Europa Foyer

Sessions: Cancer Biology & Genetics | Cancer Biomarkers | Cancer Therapy & Treatments | Oncology Nursing and Care | Cancer Pharmacology | Cancer: Psychological & Social Aspects | Surgical Oncology | Cancer Prevention & Research

Chair: Joan Smith Sonneborn, University of Wyoming, USA

Introduction

11:20-11:45Title: Prostate Health Index (PHI) can improve the ability to differentiate prostate cancer from non-cancerous conditions in prostate disease Josko Osredkar, University Medical Centre Ljubljana, Slovenia

Group Photo

11:50-12:15Title: Burnout in paediatric oncology staff and its relationship with traumatic stress, psychological flexibility and coping styles Matthew Yates, Cardiff University, UK


12:15-12:40Title: Attachment styles as predictors of postsurgical psychological adaptation of lung cancer patients Joanna Szymczak, Medical University of Gdansk, Poland

Lunch Break 12:40-13:40 @ La Place AB

13:40-14:05Title: A single centre experience of zero-ischaemia laparoscopic partial Nephrectomy for T1 renal tumors M. Falsaperla, Vittorio Emanuele – Policlinico University Hospital , Catania, Italy

14:05-14:30Title: New insights into PDGF/PDGFR axis in renal cell carcinomas Anca Maria Cimpean, Angiogenesis Research Center, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania

Sessions: Colorectal Cancer Screening | Colorectal Cancer Targeted therapy | Colorectal Cancer Genetics

Chair: Luc Colemont, CEO Stop Darmkanker Foundation, Belgium

14:30-14:55Title: Circulating miRNAs: A cancer screening biomarkers in rectal cancer Veronika Vymetalkova, Institute of Experimental Medicine, Prague, Czech Republic

14:55-15:20Title: Therapeutic effects of cationic liposomes against colon carcinoma along with apoptosis Yoko Matsumoto, Sojo University, Japan


15:40-16:05Title: Gene panel mutation screening for a better molecular stratification of colorectal cancer patients Francesca Belardinilli, University La Sapienza, Italy

16:05-16:30Title: Immunoscore® colon clinical validation and clinical utility in Stage II and Stage III colon cancer patients Karim Belaloui, HalioDx, France

16:30-16:55Title: Impact of deploying a genetic approach to stem cells opens-up new facets in the “Blank Slates” of our body Jyoti Bhojwani, DAVV/Indore University, India

Panel Discussion


Meeting Hall: Paris

Keynote Forum



09:10-09:40Title: 28 years follow up by human genotoxicity studies, risk assessment, primary prevention and cancer incidence among oil refinery workers Anna Tompa, Semmelweis University, Hungary

09:40-10:10Title: The role of DNA repair in response to treatment, disease progression and survival of sporadic colorectal cancer patients Pavel Vodicka, Institute of Experimental Medicine, Czech Republic

10:10-10:40Title: Pyloric valve transposition as substitute for a colostomy in humans Harry Goldsmith, University of California, USA


Sessions: Cancer Prevention & Research | Cancer Therapy & Treatments | Surgical Oncology Colorectal Cancer Surgery | Colorectal Cancer Diagnosis | Colorectal Cancer Research

Chair: Anna Tompa, Semmelweis University, HungaryChair: Harry Goldsmith, University of California, USA

11:00-11:25Title: Attachment styles dynamics: The impact of surgical treatment of cancer patients Joanna Szymczak, Medical University of Gdansk, Poland

11:25-11:50Title: Screening for lung cancer has limited effectiveness globally and distracts from much needed efforts to reduce critical levels of worldwide prevalence of smoking Cherian Verghese, University of Toledo Medical Center, USA

11:50-12:15Title: Effects of far-infrared & terahertz onnetsu therapy on rheumatoid arthritis and various cancers Kazuko Tatsumura, Gaia Holistic Health, USA and Japan

12:15-12:40Title: Metastatic melanoma: Surgical treatment of brain metastases - analysis of 110 patients Frances Anne McHugh, Auckland City Hospital, New Zealand

Lunch Break 12:40-13:40 @ La Place AB

13:40-14:05Title: Dealing with chemotherapy resistance: A new road to lung cancer therapy Sakhawat Ali, Beijing University of Technology, China

14:05-14:30

Title: The impact of rosuvastatin and omeg-3 on the antitumoral activity and cardiotoxicity of doxorubicin compared to captopril effect in experimentally-induced hepatocellular carcinoma in mice Ibrahim Hassen, Cairo University, Egypt

14:30-14:55Title: Current situation and development of Natural Orifice Specimen Extraction Surgery(NOSES) in colorectal cancer Shan Muhammad, The 2nd Affiliated Hospital of Harbin Medical University, China

14:55-15:20Title: Transanal minimally invasive rectal surgery Yahya Al-Abed, Colchester Hospital University NHS Foundation Trust, UK



Poster Presentations 01 15:40-16:50 @ Europa Foyer

Poster Judge: Kazuko Tatsumura, Gaia Holistic Health, USA and JapanPoster Judge: Cherian Verghese, University of Toledo Medical Center, USA

WCP-001Title: Oral administration of herbal medicines for radiation pneumonitis in lung cancer patients: A systematic review and meta-analysis Kwan-Il Kim, Kyung Hee University, Republic of Korea

WCP-002Title: Doxorubicin-induced drug resistant mechanism was inhibited by combination treatment of H12 Chan Hee Park, Chung Ang University, South Korea

WCP-003Title: Loss of TIMP-3 by promoter methylation of Sp1 binding site promotes metastasis in oral cancer Chiao-Wen Lin, Chung Shan Medical University, Taiwan

WCP-004Title: Unmet social needs of childhood cancer survivors in Japan Haruka Ono, Waseda University, Japan

WCP-005Title: A novel innate immune checkpoint inhibitor protein in tumor microenvironment Jeong Hwa Park, Konkuk University, South Korea

WCP-006Title: PGC-1α knockdown inhibits cell proliferation, migration, and invasion in human colorectal cancer SW620 cells Joo-In Park, Dong-A University College of Medicine, South Korea

WCP-007Title: Lung cancer mimicking community acquired pneumonia Marcy Canary, Bassett Medical Center – Columbia University, USA

WCP-008Title: Knockdown of COUP-TFII enhances cell proliferation, migration, invasion, and colony formation in human colorectal cancer HT-29 cells Seong-Hoon Yun, Dong-A University College of Medicine, South Korea

WCP-009Title: Functional genetic variant of long pentraxin 3 gene is associated with clinical aspects of oral cancer Shun-Fa Yang, Chung Shan Medical University, Taiwan

WCP-010Title: Antiproliferative and apoptosis inducing activity of kusunokinin and 5´-desmethoxyyatein on human cancer cells line Thidarath Rattanaburee, Prince of Songkla University, Thailand

WCP-011Title: Exploring the synergistic effect and mechanism of Spatholobus suberectus dunn extract and doxorubicin in breast MCF-7/ADR cells Wen Yi, The University of Hong Kong, China

WCP-012Title: The benefits of physical activity for cancer survivors: A literature review Yau Sui Yu, Open University of Hong Kong, Hong Kong


WCP-013Title: Apoptosis Inhibitor 5 (API5) induce cytotoxicity CD8+ T cells mediated anticancer effect through TLR4 signaling of dendritic cells Young Seob Kim, Konkuk University, South Korea

Poster Presentations 02 16:50-17:15 @ Europa Foyer

Poster Judge: Luc Colemont, CEO Stop Darmkanker Foundation, Belgium

CCP-001Title: Design, optimization and validation of genes commonly used in expression studies on DMH/AOM rat colon carcinogenesis model David Bars-Cortina, University of Lleida (Catalonia, Spain)

CCP-002Title: When to resect? Management of patients with adverse histopathological features post colonoscopic polypectomy Karen Oliva, Cabrini Monash University, Australia

CCP-003Title: Intensive second line palliative treatment in patients with colon adenocarcinoma - a case report Mariana Paula Cunha Gonçalves, Mário Penna Institute / Belo Horizonte, Brazil

CCP-004Title: The amelioration of western diet induced molecular changes in the colon by curcumin Amanda Dieckmann, University of Southern Queensland, Australia

Awards & Closing Ceremony


Extended Networking & Lunch 12:30-13:30 @ La Place AB


Glimpses ofCancer Conferences

Madrid Attractions

sagr

ada

fam

ilia

Mad

rid

Puertadel sol Madrid

Tem

ple

of d

ebod

Mad

rid

Mad

rid im

age

Parq

ue d

el B

uen

Retir

o m

adrid

Almud

ena

Cath

edra

l

Gran

Via M

adrid

Roya

l Pal

ace

Mad

rid

Plaz

a de

Cib

eles

th advances in cancer research & therapy...advances in cancer research & therapy november...

Documents